Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 32

    Eli Lilly new insulin to improve glycemic control in diabetics get positive opinion from EMA

    Eli Lilly new insulin to improve glycemic control in diabetics get positive opinion from EMA

    Farhat Nasim3 Feb 2020 3:03 PM IST
    The CHMP opinion is now referred for final action to the European Commission, which grants approval in the European Union. Lilly plans to market the...
    Emcure plea to direct NPPA to review HIV drugs price junked by DoP

    Emcure plea to direct NPPA to review HIV drugs price junked by DoP

    Farhat Nasim3 Feb 2020 1:41 PM IST
    New Delhi: In a setback to drugmaker Emcure Pharmaceuticals, the Department of Pharmaceuticals (DoP) has rejected the company's petition seeking to...
    Shilpa Medicare launches breakthrough therapy lenvatinib mesylate under brand Lenshil in India

    Shilpa Medicare launches breakthrough therapy lenvatinib mesylate under brand Lenshil in India

    MD bureau3 Feb 2020 1:22 PM IST
    Shilpa Medicare shall launch lenvatinib, at a breakthrough price which is over 50% lower than the existing brand available in India. Prior to the...
    NPPA fixes ceiling price of Immunoglobulin therapy, Details

    NPPA fixes ceiling price of Immunoglobulin therapy, Details

    Farhat Nasim2 Feb 2020 1:30 PM IST
    New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority, Ministry of Chemicals and Fertilizers, Government of India has...
    Essential medicines price capping resulted in saving of Rs 12500 crore, says Kovind

    Essential medicines price capping resulted in saving of Rs 12500 crore, says Kovind

    Farhat Nasim2 Feb 2020 12:00 PM IST
    Addressing the joint sitting of both houses of Parliament, on the first day of the Budget session here, Kovind said capping of prices of more than...
    Akcea, Ionis report positive phase 2 study results of AKCEA-ANGPTL3-LRx

    Akcea, Ionis report positive phase 2 study results of AKCEA-ANGPTL3-LRx

    MD bureau2 Feb 2020 10:30 AM IST
    Boston: Akcea Therapeutics, Inc., a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. recently announced...
    Bayer makes EMA application for a pre-filled syringe to administer eye medication Eylea

    Bayer makes EMA application for a pre-filled syringe to administer eye medication Eylea

    MD bureau2 Feb 2020 10:00 AM IST
    Berlin: Bayer has submitted an application to the European Medicines Agency (EMA) for a pre-filled syringe to administer Eylea® (aflibercept solution...
    Novacyt unveils new coronavirus test

    Novacyt unveils new coronavirus test

    Medical Dialogues Bureau2 Feb 2020 9:30 AM IST
    Novacyt said its Primerdesign coronavirus test could detect the 2019 strain of the virus, adding it believed this would differentiate it from other...
    DPCO has led to increase in prices by about 21pc for cheaper drugs: Survey

    DPCO has led to increase in prices by about 21pc for cheaper drugs: Survey

    Farhat Nasim1 Feb 2020 2:43 PM IST
    The Survey said its estimates also show that the DPCO, 2013 order increased prices by about 21 per cent for the cheaper formulations. However, in the...
    Abbott bags European nod for Tendyne Transcatheter Mitral Valve Implantation system

    Abbott bags European nod for Tendyne Transcatheter Mitral Valve Implantation system

    Medical Dialogues Bureau1 Feb 2020 1:00 PM IST
    New Delhi: Abbott today announced that its Tendyne Transcatheter Mitral Valve Implantation (TMVI) system received CE Mark and is now approved for use...
    Gilead offers to test Ebola drug remdesivir as new coronavirus treatment in China

    Gilead offers to test Ebola drug remdesivir as new coronavirus treatment in China

    Medical Dialogues Bureau1 Feb 2020 12:38 PM IST
    Gilead Sciences Inc said it was also expediting laboratory testing of the antiviral drug, remdesivir, against samples of the new coronavirus, which...
    Eugia Pharma gets USFDA nod for generic drug: Aurobindo Pharma

    Eugia Pharma gets USFDA nod for generic drug: Aurobindo Pharma

    MD bureau1 Feb 2020 10:15 AM IST
    New Delhi: Aurobindo Pharma on Friday said its joint venture firm Eugia Pharma Specialities has received approval from the US health regulator to...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Mediclaim cannot be rejected if duplicate bills are submitted: Consumer Forum on doctors plea

    Mediclaim cannot be rejected if duplicate bills are submitted: Consumer Forum on doctors plea

    Government of India bans Ofloxacin, Ornidazole injection combination

    Government of India bans Ofloxacin, Ornidazole injection combination

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok